Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2007

Open Access 01-12-2007 | Commentary

OMERACT: An international initiative to improve outcome measurement in rheumatology

Authors: Peter Tugwell, Maarten Boers, Peter Brooks, Lee Simon, Vibeke Strand, Leanne Idzerda

Published in: Trials | Issue 1/2007

Login to get access

Abstract

OMERACT is the acronym for an international, informally organized network initiated in 1992 aimed at improving outcome measurement in rheumatology. Chaired by an executive committee, it organizes consensus conferences in a 2-yearly cycle that circles the globe. Data driven recommendations are prepared and updated by expert working groups. Recommendations include core sets of measures for most of the major rheumatologic conditions. Since 2002 patients have been actively engaged in the process.
Literature
1.
Tugwell P, Boers M: OMERACT Conference on Outcome Measures in RA Clinical Trials: Introduction. J Rheumatol. 1993, 20: 528-530.PubMed
2.
Tugwell P, Bombardier C, Buchanan WW, Goldsmith CH, Grace E, Hanna B: The MACTAR Patient Preference Disability Questionnaire – an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol. 1987, 14 (3): 446-451.PubMed
3.
4.
Tugwell P, Shea B, Boers M, Brooks P, Simon L, Strand V, Wells G: From Introduction. Evidence Based Rheumatology. Edited by: Tugwell P, Shea B, Boers M, Brooks P, Simon L, Strand V, Wells G. 2004, London: BMJ Publishing Group, xiv-xv.
5.
Tugwell P, Boers M, Brooks P, Simon L, Strand V: OMERACT: an ongoing evidence based initiative to improve the quality of outcome measures in rheumatology. Evidence Based Rheumatology. Edited by: Tugwell P, Shea B, Boers M, Brooks P, Simon L, Strand V, Wells G. 2004, London: BMJ Publishing Group, 19-24.
Metadata
Title
OMERACT: An international initiative to improve outcome measurement in rheumatology
Authors
Peter Tugwell
Maarten Boers
Peter Brooks
Lee Simon
Vibeke Strand
Leanne Idzerda
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Trials / Issue 1/2007
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-8-38

Other articles of this Issue 1/2007

Trials 1/2007 Go to the issue

Study protocol

Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial

Research

Marketing and clinical trials: a case study

Research

Importance of competing risks in the analysis of anti-epileptic drug failure

Study protocol

Early loading of plalatal implants (ortho-type II) a prospective multicenter randomized controlled clinical trial

Study protocol

Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins

Study protocol

Acute cholecystitis – early laparoskopic surgery versus antibiotic therapy and delayed elective cholecystectomy: ACDC-study